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ﺩﺍﺀﺍﻟﻨﺸﻮﺍﻧﻲﺍﻷﻭﻟﻲﻟﻠﺤﻨﺠﺮﺓﻫﻮﻣﺮﺽﺣﻤﻴﺪﻧﺎﺩﺭﻏﻴﺮﻣﻌﺮﻭﻑﺍﻟﺴﺒﺐ.
ﻭَﺗﻌُﺮﺽﻟﺴﺎﻥﺍﻟﻤﺰﻣﺎﺭﻓﻘﻂﺑﺪﺍﺀﺍﻟﻨﺸﻮﺍﻧﻲﻫﻮﻣﻦﺃﻣﺮﺍﺽﺍﻟﺤﻨﺠﺮﺓﺍﻟﺤﻤﻴﺪﺓﻏﻴﺮ
ﺍﻟﻤﺄﻟﻮﻓﺔﺍﻟﺘﻲﺗﻈﻬﺮﻛﺈﺣﺴﺎﺱﺑﺠﺴﻢﻏﺮﻳﺐﻓﻲﺍﻟﺤﻠﻖ.ﻭﻳﺠﺐﻭﺿﻊﻫﺬﺍﺍﻟﻤﺮﺽ
ﻓﻲﺍﻻﻋﺘﺒﺎﺭﻓﻲﺣﺎﻟﺔﺍﻹﺣﺴﺎﺱﺑﺠﺴﻢﻏﺮﻳﺐﺑﺎﻟﺤﻠﻖﻟﻤﺪﺓﻃﻮﻳﻠﺔ.ﺍﻟﻤﻼﺣﻈﺔ
ﻭﺍﻻﺳﺘﺌﺼﺎﻝﺑﺎﻟﻤﻨﻈﺎﺭﺑﺎﺳﺘﺨﺪﺍﻡﻟﻴﺰﺭﺛﺎﻧﻲﺃﻛﺴﻴﺪﺍﻟﻜﺮﺑﻮﻥﻫﻮﻃﺮﻳﻘﺔﺍﻟﻌﻼﺝ
ﺍﻟﺮﺋﻴﺴﺔ.ﻫﻨﺎﻙﺣﺎﺟﺔﺃﻳﻀﺎﻟﻠﻤﺘﺎﺑﻌﺔﻋﻠﻰﺍﻟﻤﺪﻯﺍﻟﻄﻮﻳﻞﺑﺴﺒﺐﻃﺒﻴﻌﺔﺍﻟﻤﺮﺽ
ﺍﻟﺒﻄﻴﺌﺔﻭﺍﻟﻤﺘﺮﻗﻴﺔ.
ﺍﻟﻜﻠﻤﺎﺕﺍﻟﻤﻔﺘﺎﺣﻴﺔ:ﺍﻟﻨﺸﻮﺍﻧﻲ؛ﻟﺴﺎﻥﺍﻟﻤﺰﻣﺎﺭ؛ﺍﻹﺣﺴﺎﺱﺑﺠﺴﻢﻏﺮﻳﺐﺑﺎﻟﺤﻠﻖ
Abstract
Primary amyloidosis of the larynx is a rare benign disease
of unknown aetiology. Isolated epiglottic involvement
with amyloidosis is an extremely uncommon benign
laryngeal pathology and can present with a foreign body
sensation in the throat. This lesion should be kept in
mind in cases with a long-standing foreign body sensation
in the throat. Observation and endoscopic carbon dioxide
laser excision are the main methods of treatment. Long-
term follow-up is also required because of the slow pro-
gressive nature of this disease.* Corresponding address: Department of ENT, IMS & SUM
Hospital, Kalinga Nagar, Bhubaneswar-3, Odisha, India.
E-mail: santoshvoltaire@yahoo.co.in (S.K. Swain)
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Isolated laryngeal amyloidosis is an extremely rare lesion
representing 1% of all benign laryngeal tumours.1
Amyloidosis was first described by Rokitansky in 1842. The
term amyloid was coined by Virchow, who found that it
stained violet with iodine and sulphuric acid; he attributed
this to its cellulose or starch-like nature.2 Laryngeal
amyloidosis was first documented in 1875 during a post-
mortem examination.3 It is characterized by the deposition
of homogenous eosinophilic extra-cellular materials in the
laryngeal tissue; this material is protein in nature. Laryngo-
scopic findings are not very characteristic, and the diagnosis is
based on histopathology. Staged microlaryngeal excision
using a carbon dioxide (CO2) laser is the treatment of choice.
Because of its rarity and clinical interest, here, we report a case
of localized amyloidosis involving the epiglottis in a 45-year-
old female patient who presented with an unusual symptom
described as a long-standing foreign sensation in the throat.
Case report
A 45-year-old female came to the outpatient department
of otorhinolaryngology and presented with a foreign body
sensation in the throat that had persisted for three years.his is an open access article under the CC BY-NC-ND license
16/j.jtumed.2015.07.004
Figure 1: Video laryngostroboscopic picture showing the isolated
mass over the laryngeal surface of the epiglottis (marked by the
arrow).
S.K. Swain and M.C. Sahu 489Indirect laryngoscopic examination of the larynx showed a
smooth swelling over the lingual surface of the epiglottis. The
laryngostroboscopic video examination confirmed the same
findings (Figure 1). The false vocal cords, arytenoids,
ventricles, true vocal cords and subglottis appeared normal.
The mobility of the vocal cords was normal. She had no
history of shortness of breath or stridor. The general
examination showed a good general condition, with no
breathlessness or dysphagia. Her vital signs were normal,
and she had no palpable neck nodes. The ear, nose,
pharynx and oral cavity examinations were normal.
Complete blood counts (CBC), thyroid functions test
(TFT), liver functions test (LFT), C-reactive proteins, ECG
and chest X-ray were normal. A computed tomography
(CT) scan of the neck with omnipaque contrast revealed a
localized enhanced soft tissue mass measuring
1.5 cm  1 cm in diameter over the lingual surface of the
epiglottis (Figure 2). Microlaryngoscopy was performed
under general anaesthesia, and the lesion was firm in
consistency. The tissue from the mass lesion was sent for
histopathological examination. In histopathological
examination, the excised polypoidal mass revealed
amorphous deposits of eosinophilic, proteinaceous material
within the subepithelial stroma (Figure 3a), and this was
confirmed as amyloidosis after positive staining with Congo
red stain (Figure 3b). The full blood count and erythrocyte
sedimentation rates were normal. With a confirmed
diagnosis of the mass over the epiglottis, a carbon dioxide-
assisted microlaryngeal surgery was performed under gen-
eral anaesthesia. The epiglottic amyloidosis was resected with
a CO2 laser. The patient is now under regular follow-up care
every six months and performs video laryngostroboscopy to
rule out any evidence of local recurrence in the larynx. To
date, she has had no complaints of a foreign body sensation in
her throat.Figure 2: Axial cuts of the CT scan of the neck showing a mass in
the epiglottis.Discussion
Amyloidosis is characterized by the extracellular depo-
sition of proteinaceous material in the tissue. The incidence
of amyloidosis is estimated to be 5 to 9 cases per million
per year throughout the world. It is more frequently
observed in developed countries.4 The amyloid is stained
with iodine, metachromatic dyes, methylviolet and Congo
red. It has a 3:1 male to female predominance and is
common between the 5th and 7th decades of life.5
Amyloidosis can be genetic or acquired.6 Out of 15
biochemical forms of amyloidosis, the common three
types are: i. AL (light chain): derived from plasma cells
and contains kappa and lambda immunoglobulin light
chains; ii. AA (amyloidosis associated): amyloidosis is a
nonimmunoglobulin protein synthesized by the liver. It is
a reactive systemic amyloidosis. iii. AB: amyloidosis
found in Alzheimer’s disease and sometimes familial cases.
Clinically, amyloidosis can be classified into two types:
primary amyloidosis, in which there is spontaneous
development of an amyloid deposit, and secondary
amyloidosis, which is found in conjunction with some
other systemic diseases, such as Rheumatoid arthritis or
tuberculosis.7 Primary amyloidosis can be further divided
into localized and generalized forms. The larynx is rarelyaffected with amyloidosis. The most common part of the
larynx that is affected is the vestibule, followed by the
false cords, the aryepiglottic folds and the subglottic
region.8 The false vocal cords and the ventricles of the
larynx are most commonly affected, and they show
smooth, submucosal nodular to diffuse deposits under an
intact surface epithelium. In the larynx, the amyloid can
be observed as subepithelial extracellular deposits of
acellular, homogenous and amorphous eosinophilic
materials displaying apple-green birefringence with polar-
ized light when stained with Congo red or metachromatic
with crystal violet or methyl violet.9 Our case showed
primary involvement of the epiglottis without affecting
the glottis or laryngeal airway.
Figure 3: a: Amyloid lesion of the epiglottis showing glossy eosinophilic H and E staining at 10 magnification. b: Congo red stain of the
tissue from an epiglottic mass showing the typical salmon pink staining of the amyloid at 10 magnification.
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of amyloidosis are hoarseness, nasal congestion, odynopha-
gia, articulation problems, mandibular deformities, degluti-
tion difficulties, airway obstruction, speech disorders and
hypogeusia.10 Herein, the patient presented with a long-
standing foreign body sensation in the throat, which is
rarely reported in head and neck amyloidosis.
In the CT scan, the amyloidosis appeared as a marked
thickening of the laryngeal soft tissue with a high density
appearance, whereas in MRI, the amyloidosis had the same
signal density as skeletal muscle. This may help to differen-
tiate amyloidosis of the larynx because tumours do not
appear in this manner in MRI.11
Based upon the involvement of organs of the body and
histological evidence of amyloid deposits, a diagnosis is
made. The outcome of the investigations differs from patient
to patient. Because no blood test is diagnostic for amyloid, a
final diagnosis is usually made on the basis of tissue biopsy.
Biopsies can be taken from almost any organ based upon the
clinical symptoms. In our case, a biopsy from the epiglottic
mass was carried out after endoscopic confirmation
following the patient’s symptoms. Immunohistochemical
stains and Congo red staining observed under polarized light
microscopy or the electron microscopic findings of a laryn-
geal biopsy specimen can confirm the diagnosis of the amy-
loid.12 Lewis et al. recommended urine and serum
electrophoresis as a basic approach for diagnosis of
patients suffering from amyloidosis that is observed
exclusively in the larynx.13 Amyloid protein is detected
histologically by staining the samples with Congo red stain,
which imparts an apple-green colour to the amyloid pro-
tein. In polarized light, the amyloid appears birefringent.
Treatment varies from simple observation of the lesion, if
the lesion is asymptomatic, to surgical excision, when the
lesion is symptomatic. Presently, the most effective treat-
ment of this lesion is CO2 laser-assisted surgical excision.
Extensive amyloidosis that compromises the laryngeal
airway may be treated either with an endoscopic approach
or an external approach. Radiotherapy and medical treat-
ment with steroids are ineffective. A new therapeutic mo-
dality for amyloidosis involving an experimental small
molecule drug called R-1-[6-[R-2-Carboxy-Pyrrolidin-1-Y1]-
6-Oxo-hexanoyl]Pyrrolidine-2-Caboxyic acid (CPHPC) that
depletes the serum amyloid P component (SAP) has been
developed by Pepys et al.14 SAP binds to amyloid fibrils and
makes them resistant to degradation. CPHPC interferes withSAP binding to amyloid fibrils and leads to the rapid
clearance of SAP by the liver. Localized amyloidosis has
an excellent prognosis in comparison to the systemic
variety. Long-term follow up is required because of the
slow progressive nature of the disease.15Conclusion
Laryngeal amyloidosis is a rare and benign clinical con-
dition. Isolated primary epiglottic amyloidosis is an
extremely rare condition. It may present with a foreign body
sensation in the throat. Thus, this lesion should be kept in
mind in cases with long-standing foreign body sensation in
the throat. An endoscopic CO2 laser is an excellent treatment
option for this type of localized laryngeal lesion. There must
be regular follow ups to rule out local recurrence.Conflict of interest
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